Are you Dr. Irizarry?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1400 Pelham Pkwy S
Bronx, NY 10461Phone+1 718-918-5820Fax+1 718-798-0730
Summary
- Dr. Eddie Irizarry, MD is a board certified emergency medicine physician in Bronx, New York. He is currently licensed to practice medicine in New York. He is affiliated with Montefiore Medical Center and NYC Health + Hospitals / South Brooklyn Health.
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine (Jacobi/Montefiore)Residency, Emergency Medicine, 2007 - 2011
- Albert Einstein College of MedicineClass of 2007
Certifications & Licensure
- NY State Medical License 2009 - 2026
- American Board of Emergency Medicine Emergency Medicine
Clinical Trials
- A Comparison of NSAIDs for Acute, Non-radicular Low Back Pain. Start of enrollment: 2019 Jul 12
- Dexamethasone for Migraine - Dose Comparison Start of enrollment: 2019 Dec 22
Publications & Presentations
PubMed
- 6 citationsA Randomized Study of Intravenous Hydromorphone Versus Intravenous Acetaminophen for Older Adult Patients with Acute Severe Pain.Shilpa Kolli, Benjamin W Friedman, Alex Latev, Andrew K Chang, Farnia Naeem
Annals of Emergency Medicine. 2022-11-01 - 3 citationsRandomized Trial Comparing Low- vs High-Dose IV Dexamethasone for Patients With Moderate to Severe Migraine.Benjamin W Friedman, Clemencia Solorzano, Benjamin D Kessler, Kristina Martorello, Carlo L Lutz
Neurology. 2023-10-03 - 5 citationsA randomized controlled trial of ibuprofen versus ketorolac versus diclofenac for acute, nonradicular low back painEddie Irizarry, Andrew Restivo, Maha Salama, Michelle Davitt, Carmen Feliciano
Academic Emergency Medicine. 2021-06-30
Press Mentions
- IV Opioids for Acute Pain Unlikely to Lead to OUDNovember 12th, 2024